ArticleBlood2017

Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.

Benoit M Cyrenne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.